Manchester & London Investment Trust PLC
Total Voting Rights
1 July 2009
In accordance with the FSA's Disclosure and Transparency Rules, Manchester &
London Investment Trust PLC ("the Company") notifies the market of the
following:
As at the close of business on 30 June 2009, the Company's issued share capital
consisted of 17,430,842 ordinary shares with a nominal value of 25p each
('Ordinary Shares'), with voting rights. The Company does not hold any Ordinary
Shares in Treasury.
Therefore, the total number of Ordinary Shares with voting rights is
17,430,842.
The above figure of 17,430,842 Ordinary Shares may be used by shareholders in
the Company as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change in
their interest in, the share capital of the Company under the FSA's Disclosure
and Transparency Rules.
Enquiries:
Midas Investment Management PLC, Investment Manager
Mark Sheppard, Chief Investment Officer Tel: 020 7225 1836
Fairfax I.S. PLC, Sponsor and financial adviser
David Floyd Tel: 020 7460 4358
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.